CDC’s Diagnostic Multiplex Assay for Flu and COVID-19 and Supplies

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated Oct. 25, 2020
  
  The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The assay provides a sensitive, nucleic-acid-based diagnostic tool for evaluation of specimens from patients in the acute phase of infection.
  
  How Public Health Laboratories Order the Flu SC2 Multiplex Assay -- Materials included in the assay -- Other materials labs need to perform the assay -- More Resources for the Flu SC2 Multiplex Assay -- Fact Sheets for the Flu SC2 Multiplex Assay -- More Resources for Diagnostic Testing for COVID-19 and Flu.
  
  
• Subjects:
  Betacoronavirus Clinical Laboratory Techniques Coronavirus Infections/diagnosis COVID-19 Nucleic Acid Testing COVID-19 Serological Testing COVID-19 Testing Diagnostic Tests, Routine Laboratories Pneumonia, Viral/diagnosis Reagent Kits, Diagnostic Real-Time Polymerase Chain Reaction Serologic Tests

  More +
• Series:
  Coronavirus Disease 2019 (COVID-19)
• Document Type:
  Text
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:e7e1cfd6a1201443c8597baac0a61df8364355a8ff568fe8eb2d2713d1ba1d4adccf33056849b5fc2c9ef8152eab10f32eb744d18d02a846cf62e0ca5b807a41
• Download URL:
  https://stacks.cdc.gov/view/cdc/96006/cdc_96006_DS1.pdf
• File Type:
  [PDF - 185.06 KB ]